Nxera Pharma Co (Nxera Pharma Co) Long-Term Capital Lease Obligation : $26.6 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Long-Term Capital Lease Obligation?

Nxera Pharma Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $26.6 Mil.

Nxera Pharma Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 ($28.4 Mil) to Dec. 2023 ($27.7 Mil) and declined from Dec. 2023 ($27.7 Mil) to Mar. 2024 ($26.6 Mil).

Nxera Pharma Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($14.4 Mil) to Dec. 2022 ($11.7 Mil) but then increased from Dec. 2022 ($11.7 Mil) to Dec. 2023 ($27.7 Mil).

Nxera Pharma Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Nxera Pharma Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Long-Term Capital Lease Obligation Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

15.62

16.03

14.39

11.69

27.68

Nxera Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															11.93	14.30	28.40	27.68	26.58

Nxera Pharma Co (OTCPK:SOLTF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Nxera Pharma Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.